TRI 4.76% 2.2¢ trivarx ltd

Ann: Clinical Study Shows Improvement to Diagnostic Standard, page-2

  1. 160 Posts.
    lightbulb Created with Sketch. 36
    Great announcement!

    I want to squash any potential adverse reaction to this announcement in case people get carried away as to why the results aren't as strong as previously reported, I draw your attention to pg.3 of the announcement.

    Comparison to Prior Studies
    Early development phases of this algorithm, including the previously reported MACH-3 pilot study results (August 2017), were used to support this hypothesis with respect to initial clinical study protocol and functionality. Prior studies were based on a low hypothesis rate, had low study subjects, used a limited number of study sites, and were completed in controlled environments.


    I also note we have a VP, Integrated Health appointed overnight. It certainly appears as though it is business-as-usual!

    Just need funding sorted and we are away!

    Mr.G
    Last edited by Mr.G: 06/09/18
 
watchlist Created with Sketch. Add TRI (ASX) to my watchlist
(20min delay)
Last
2.2¢
Change
0.001(4.76%)
Mkt cap ! $10.05M
Open High Low Value Volume
2.2¢ 2.2¢ 2.2¢ $340 15.45K

Buyers (Bids)

No. Vol. Price($)
2 30024 2.2¢
 

Sellers (Offers)

Price($) Vol. No.
2.3¢ 192750 1
View Market Depth
Last trade - 10.27am 16/08/2024 (20 minute delay) ?
TRI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.